No-fault indemnity scheme a boost to vaccine rollout

Vaccinating children for COVID-19

Would you like to contribute to the regulation of therapeutic goods?

TGA provisionally approves Moderna's COVID-19 vaccine

ePrescription SMS subsidy extended to 30 June 2022

AMA Fees List update: Orthopaedic items

New rules for Active Ingredient Prescribing

Time for calm debate on COVID-19 vaccinations for children

Pharmacy grace period for Active Ingredient Prescribing ends this month

AMA submission to the Therapeutic Goods Administration – Proposed refinements to the regulation of personalised medical devices

AMA's Medical Journal of Australia hits new high for impact

Vaccine allocations by State/Territory

AMA submission to the Therapeutic Goods Administration – Proposed improvements to the Therapeutic Goods Advertising Code

ATAGI changes AstraZeneca guidelines

More support for general practice in vaccine rollout urgently needed

AMA opposes application to down-schedule oral contraceptive pills

AMA welcomes transparency on revised ATAGI advice on vaccines

Dr Omar Khorshid - MBS changes and comments on quarantine

Government in danger of history repeating with Medicare rebate changes

AMA submission to the Therapeutic Goods Administration – Proposed amendments to the Poisons Standard – June 2021 – oral contraceptives